Discontinued drugs in 2012: cardiovascular drugs.
EXPERT OPINION ON INVESTIGATIONAL DRUGS（2013）
摘要
This perspective is part of an annual series of papers discussing drugs dropped from development in the previous year. Specifically, this paper focuses on the 19 cardiovascular drugs discontinued in 2011 after reaching preclinical or Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
更多查看译文
关键词
ADX-415,alipogene tiparvovec,antihypertensives-NicOx-1,antihypertensives-NicOx-2,avotermin,BMS-844421,budiodarone,celivarone,cinaciguat,darexaban maleate,flovagatran,GRNCM1,GS-9667,letaxaban,OBE-101,PPD-10558,SB-509,sirolimus stent-J&J,tecarfarin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要